Calavo Growers (NASDAQ: CVGW) furnishes Q4 and FY 2025 results press release

Rhea-AI Filing Summary

Calavo Growers, Inc. filed a current report to disclose that it issued a press release with its financial results for the three-month and twelve-month periods ended October 31, 2025. The press release, dated January 14, 2026, is furnished as Exhibit 99.1 and contains the detailed results of operations and financial condition for those periods.

The company notes that this information, including Exhibit 99.1, is being furnished under a provision that means it is not treated as filed for certain liability purposes under the federal securities laws and is only incorporated into other filings if specifically referenced.

0001133470false00011334702026-01-142026-01-14

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): January 14, 2026

CALAVO GROWERS, INC.

(Exact name of registrant as specified in its charter)

​

​	​	​	​	​
California	​ ​	000-33385	​ ​	33-0945304
(State or other jurisdiction of incorporation)	​	(Commission File Number)	​	(IRS Employer Identification No.)

​

1141-A Cummings Road, Santa Paula, California 93060

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (805) 525-1245

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☒  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

​

​

​	​	​	​	​
Title of each class	​ ​	Trading Symbol(s)	​ ​	Name of each exchange on which registered
Common Stock	​	CVGW	​	Nasdaq Global Select Market

​

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

​

​

Item 2.02. Results of Operations and Financial Condition.

On January 14, 2026, Calavo Growers, Inc., (the “Company”) issued a press release announcing our financial results for the three-month and twelve-month periods ended October 31, 2025.  A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K.

In accordance with General Instruction B.2 of Form 8-K, the information contained in this Item 2.02, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

​

​

Item 9.01. Financial Statements and Exhibits.

​	​	​
(d)	Exhibits	​
​	99.1	Press Release dated January 14, 2026 of the Company.
​	104	Cover Page Interactive Data File (embedded within the Inline XBRL document).

​

​

​

​

​

2

​

​

​

​

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

​	Calavo Growers, Inc.
January 20, 2026	​
​	By:	/s/ B. John Lindeman
​	Name:	B. John Lindeman
​	Title:	President and Chief Executive Officer
​	​	(Principal Executive Officer)

​

​

​

3

FAQ

What did Calavo Growers, Inc. (CVGW) disclose in this Form 8-K?

Calavo Growers, Inc. disclosed that it issued a press release announcing its financial results for the three-month and twelve-month periods ended October 31, 2025. The press release is furnished as Exhibit 99.1.

Which periods do the Calavo Growers (CVGW) results in the press release cover?

The results disclosed in the press release cover the three-month and twelve-month periods ended October 31, 2025.

How is the earnings information in this Calavo Growers (CVGW) Form 8-K treated under securities laws?

The information in Item 2.02, including Exhibit 99.1, is furnished and not deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, and is only incorporated into other filings if specifically referenced.

What exhibit is included with this Calavo Growers, Inc. (CVGW) Form 8-K?

The Form 8-K includes Exhibit 99.1, which is the press release dated January 14, 2026, and Exhibit 104, the cover page interactive data file embedded within the Inline XBRL document.

Who signed this Calavo Growers (CVGW) Form 8-K?

The report was signed on behalf of Calavo Growers, Inc. by B. John Lindeman, President and Chief Executive Officer, identified as the principal executive officer.

Does this Calavo Growers (CVGW) Form 8-K itself contain detailed financial figures?

This Form 8-K states that detailed financial results are included in the press release furnished as Exhibit 99.1, rather than within the body of the report.